EU antitrust regulators will open an extensive probe into Zimmer's (ZMH.N) $13.4 billion bid for Biomet, concerned that the creation of the world's second-largest orthopedic products group may hurt competition, three people familiar with the matter said on Thursday.
Tags: Eli Lilly
FDA Committee Endorses Eli Lilly’s Alzheinmer’s Drug
The Food and Drug Administration’s advisory committee endorsed Eli Lilly’s Alzheimer’s drug, donanemab, for approval to further slow the aggression of the specific type of dementia in patients despite criticisms regarding test patient deaths during clinical trials.
Telehealth Startup Ro Develops Online Tracker to Combat Wegovy Shortages Amid Weight-Loss Drug Demand
Telehealth startup Ro has launched a free online tracker to help patients and doctors locate in-stock weight-loss drugs like Wegovy amid national shortages, providing real-time availability and the option to report outages to the FDA.
Amgen Challenges Novo Nordisk, Eli Lilly in Weight Loss Drug Market as Investors Flock for Next Obesity Drug Payout
Amgen witnessed an impressive 12% surge in its shares on Friday, marking its most substantial single-day increase in nearly 15 years.
Alphabet’s Isomorphic Labs Partners With Eli Lilly, Novartis to Accelerate AI-Driven Drug Discovery
Isomorphic Labs, a subsidiary of Alphabet Inc., is set to accelerate AI-driven drug discovery after it entered into strategic research collaboration agreements with Novartis AG and Eli Lilly & Co.
Latest News
California big data startup BlueTalon bags $1.5M in seed funding for single-click data collaboration
California-based big data startup BlueTalon bagged $1.5 million in a seed funding round from Data Collective for its single-click data collaboration offering for enterprises.
Eli Lilly Chairman, John Lechleiter has returned to work after heart surgery. Chairman and Chief Executive Officer of Eli Lilly & Co. , John Lechleiter returned to his positions full-time after undergoing a heart surgery to fix a heart defect in May.
Eli Lilly, in its bid to remain at the forefront of Alzheimer's diagnostics, purchases Siemen's imaging agents.
